title: UK partnership targets lung cancer.
abstract: Cancer Research UK has joined with two major pharmaceutical companies to launch a large multiarm clinical trial, dubbed the National Lung Matrix trial, to test the effectiveness of promising experimental therapies in treating rare forms of advanced lung cancer.
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents